A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)

NCT00293254 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: raltegravir potassium
DRUG: Comparator: placebo

Sponsor

Merck Sharp & Dohme LLC